Park YH, Nam HW. Clinical features and treatment of ocular toxoplasmosis. Korean J Parasitol 2013; 51(4): 393–399.
Bodaghi B, Touitou V, Fardeau C, et al. Toxoplasmosis: new challenges for an old disease. Eye 2012; 26(2): 241–244.
Suresh S, Nor-Masniwati S, Nor-Idahriani MN , et al. Serological IgG avidity test for ocular toxoplasmosis. Clin Ophthalmol 2012; 6:147–150.
Ngui R, Lim YA, Amir NF, et al. Seroprevalence and source of toxoplasmosis among orang asli (indigenous) communities in penisular Malaysia. Am J Trop Med Hyg 2011; 85(4): 660–666.
Commodaro AG, Belfort RN , Rizzo LV, et al. Ocular Toxoplasmosis – an update and review of the literature. Mem Inst Oswaldo Cruz 2009; 104(2): 345–350.
Lim VK, Tan PL. Ocular toxoplasmosis in Malaysia. Med J Malaysia 1983; 38(3): 185–187.
Weiss LM, Dubey JP. Toxoplasmosis: a history of clinical observation. Int J Parasitol 2009; 39(8): 895–901.
Zierhut M, Deuter C, Murray PI. Classification of uveitis – current guidelines. European Ophthalmic Review 2007; 77–78, doi: http:// doi.org/10.17925/EOR.2007.00.00.77.